The role of cytoreductive surgery in the management of progressive glioblastoma

摘要: Should patients with previously diagnosed malignant glioma who are suspected of experiencing progression the neoplasm process undergo repeat open surgical resection? These recommendations apply to adults neoplastic and amenable resection. Repeat cytoreductive surgery is recommended in symptomatic locally recurrent or progressive glioma. The median survival these patient glioblastoma expected range from 6 17 months following a second procedure. It that preoperative factors be considered when evaluating for operation: location recurrence eloquent/critical brain regions, Karnofsky Performance Status tumor volume.